FDG PET/CT in Patients With HIV
- 1 August 2011
- journal article
- review article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 197 (2) , 284-294
Abstract
OBJECTIVE. This article will discuss the 18F-FDG normal variant uptake and the role of FDG PET/CT in malignancies in HIV-infected patients, CNS manifestations of HIV, assessing fever of unknown origin in HIV patients, assessing response to highly active antiretroviral therapy and assessing complications. CONCLUSION. FDG PET/CT is a valuable imaging study in the management of HIV-infected patients.Keywords
This publication has 56 references indexed in Scilit:
- PET/CT in the Evaluation of Lymphoma in Patients With HIV-1 With Suppressed Viral LoadsClinical Nuclear Medicine, 2008
- Prevention and treatment of the immune reconstitution inflammatory syndromeCurrent Opinion in HIV and AIDS, 2008
- Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy eraJournal of NeuroVirology, 2005
- AIDS‐related lymphomas: from pathogenesis to pathologyBritish Journal of Haematology, 2005
- Highly Active Antiretroviral Therapy in AIDS-Associated Kaposi's Sarcoma (KS): Implications for the Design of Therapeutic Trials in Patients With Advanced Symptomatic KSJournal of Clinical Oncology, 2005
- Positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancerMolecular Imaging and Biology, 2004
- Differential Diagnosis of CNS Lesions in AIDS Patients by FDG-PETJournal of Computer Assisted Tomography, 1995
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Expression of glycolytic isoenzymes in activated human peripheral lymphocytes: Cell cycle analysis using flow cytometryExperimental Cell Research, 1991
- Cell-Free HIV in Lymph Nodes of Patients with AIDS and Generalized LymphadenopathyNew England Journal of Medicine, 1988